Full text
PDF![1345](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a34/2551248/7c89421db6b1/bmj00619-0037.png)
![1346](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a34/2551248/48dc6a2f12d5/bmj00619-0038.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Golledge C. L., McKenzie T., Riley T. V. Extended spectrum cephalosporins and Clostridium difficile. J Antimicrob Chemother. 1989 Jun;23(6):929–931. doi: 10.1093/jac/23.6.929. [DOI] [PubMed] [Google Scholar]
- Green S. T., Mackie R., McMillan H., Davie J. W. Clostridium difficile induced colitis occurring during cefotaxime therapy. Ulster Med J. 1985 Apr;54(1):80–82. [PMC free article] [PubMed] [Google Scholar]
- Pear S. M., Williamson T. H., Bettin K. M., Gerding D. N., Galgiani J. N. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994 Feb 15;120(4):272–277. doi: 10.7326/0003-4819-120-4-199402150-00003. [DOI] [PubMed] [Google Scholar]